Maternal And Fetal Outcomes in Pregnant Women With Liver Disease

Completed

• Conditions: Fulminant Hepatic Failure

• Registration Number: NCT06594237
• Lead Sponsor: Muhammad Aamir Latif

Brief Summary

Liver disease complications during pregnancy can impact maternal and neonatal health, though not many studies are on view to investigate maternal and fetal outcomes in Pakistani pregnant women. So, this study was aimed to determine the maternal and fetal outcomes among pregnant females with liver disease.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-01
• Primary Completion: 2024-08-31
• Study Completion: 2024-08-31
• Status Verified: 2024-09
• Study First Submitted: 2024-09-10
• Study First Submitted QC: 2024-09-10
• Last Update Submitted: 2024-09-10
• Study First Posted: 2024-09-13
• Last Update Posted: 2024-09-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 195

Inclusion Criteria

• Pregnant females with liver disease
• With gestational age > 24 weeks
• Any parity or gravidity status

Exclusion Criteria

• Pregnant females with renal disease or any kind of malignancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maternal or Fetal survival or mortality.	24 hours	Fetal and maternal outcomes in terms of survival or death were noted.

Trial Locations

Locations (1)

Nishtar Medical University; 🇵🇰 Multan, Punjab, Pakistan